Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00133107 · ClinicalTrials.gov registry record · NA
Safety and Effectiveness of Efalizumab to Treat Oral Lichen Planus
A NA study of Lichen Planus, Oral, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- NA
- Development phase
- 4
- Enrollment target
- 1
- Study location
NCT00133107: Completed NA study of Lichen Planus, Oral, sponsored by Washington University School of Medicine.
NCT00133107 is a NA study of Lichen Planus, Oral that has completed, run by Washington University School of Medicine. The registered enrollment target is 4 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00133107, a NA study of Lichen Planus, Oral, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is to determine whether efalizumab 1.0mg/kg given by subcutaneous injection for 12 weeks is effective in treating oral lichen planus. This is a 20 week, single center, open-label pilot study to enroll 5 subjects.
Primary Outcome
area of oral mucosa involvement was measured in cm2 at baseline, week 4, week 8, week 12 and week 20. the primary efficacy outcome measure was the change in oral mucosal involvement at week 12.
Conditions Studied
Interventions
- DRUG efalizumab
Study Locations (1)
Missouri
- Washington University - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2005-01 |
| Est. Completion | 2005-11 |
| Phase | NA |
What the finished NCT00133107 record still lists
NCT00133107 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Lichen Planus, Oral appearing as the primary indexed condition, and to 1 intervention - of which efalizumab is the first listed.
NCT00133107 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT00133107 about?
NCT00133107 is a clinical study titled "Safety and Effectiveness of Efalizumab to Treat Oral Lichen Planus". This study is to determine whether efalizumab 1.0mg/kg given by subcutaneous injection for 12 weeks is effective in treating oral lichen planus. This is a 20 week, single center, open-label pilot study to enroll 5 subjects.
What is the current status of trial NCT00133107?
This trial is currently completed. It is a NA study. The enrollment target is 4 participants. The study started on 2005-01. Estimated completion is 2005-11.
What conditions does trial NCT00133107 study?
This clinical trial studies the following conditions: Lichen Planus, Oral.
What interventions are being tested in trial NCT00133107?
The interventions under investigation include: efalizumab (DRUG).
Who is sponsoring clinical trial NCT00133107?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00133107 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lichen Planus, Oral
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00133107's enrollment target sits among peer trials
4 1996th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia